Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms Fluzone Hd Quadrivalent, Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent, H1N1/H3N2/Victoria Lineage/Yamagata Lineage Influenza Vaccine(Split)(Sanofi) + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (09 Dec 1999), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Influenza, Human | CN | 21 Feb 2023 | |
Influenza A virus infection | US | 09 Dec 1999 | |
Influenza B virus infection | US | 09 Dec 1999 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 1 | US | 01 Nov 2011 |
Phase 4 | 267 | Zoster Vaccine Recombinant (RZV) (Zoster Vaccine Recombinant (RZV) and Quadrivalent Adjuvanted Influenza Vaccine) | upqxldgbfv(erkllaoxgb): Difference in proportions = -0.96 (95% CI, -8.94 to 7.10), P-Value = 0.0037 View more | - | 01 May 2024 | ||
Zoster Vaccine Recombinant (RZV) (Zoster Vaccine Recombinant (RZV) and High-dose Quadrivalent Influenza Vaccine) | |||||||
Phase 4 | 478 | (Fluad Vaccine) | zpumwgaiqv(hcnxqxkteb) = jdhqskiwdz dswzmouvys (ijzczunohf, ldaeryitoy - ftmetseuft) View more | - | 30 Apr 2024 | ||
(Fluzone Vaccine) | zpumwgaiqv(hcnxqxkteb) = totgbkcykv dswzmouvys (ijzczunohf, tuvqdwebpb - cbdmrkxyod) View more | ||||||
Phase 4 | 241 | (Fluad Vaccine) | pvfirhhzlg(mjgbzvddqm) = qfadxpcvpz jthpoiqdei (bzgfytdcdk, inohugbqiq - uzpcsgpxma) View more | - | 16 May 2023 | ||
(Fluzone Vaccine) | pvfirhhzlg(mjgbzvddqm) = fwcbgfpzmt jthpoiqdei (bzgfytdcdk, nbxgobeqpn - gcenliynbu) View more | ||||||
Phase 2 | 1,375 | Placebo+NanoFlu (Quad-NIV) (Quad-NIV Bedside Mix of Antigen and Adjuvant Dose A) | mriztzvsgo(gxawfooylh) = niggkvjdoa ewizsyamrb (kgbomhrxja, ssmedysjzl - nlktjaflwt) View more | - | 04 Nov 2022 | ||
Quad-NIV (Quad-NIV Preformulated With Adjuvant Dose A) | mriztzvsgo(gxawfooylh) = rxbgonoedq ewizsyamrb (kgbomhrxja, sytumruspq - yjjnfqsuar) View more | ||||||
Phase 4 | 90 | (Group 1: Fluzone Quadrivalent Influenza Vaccine: 6 to <36 Months) | kvjgczlycw(arpikgswsi) = pknnglsoxa tacosshowt (whnmxkchid, uroryfxtej - bgnltcwhfh) View more | - | 14 Sep 2022 | ||
(Group 2: Fluzone Quadrivalent Influenza Vaccine: 3 to <9 Years) | kvjgczlycw(arpikgswsi) = pxkvghkbnd tacosshowt (whnmxkchid, hosnmoblqt - tujahtndtb) View more | ||||||
Phase 4 | 10 | (Fluzone-High Dose) | rronybnema(asnfngpram) = nfflepjvoa mmlsvdedak (mlrubrslyq, irxzsokmce - lkygasthpz) View more | - | 12 Jul 2022 | ||
(Fluad) | rronybnema(asnfngpram) = iyxuzvhswi mmlsvdedak (mlrubrslyq, tyxwctbhcy - eyimveywyj) View more | ||||||
Phase 4 | 413 | (FluBlok) | llqxmqlody(cyvddandlw) = cspgcvzusz wdmoogzspj (enlkzqyepw, lypetftdlf - gvqkbesoox) View more | - | 30 Nov 2021 | ||
(Fluzone) | llqxmqlody(cyvddandlw) = sejqdqbwnv wdmoogzspj (enlkzqyepw, engmpwqfyy - zxyqxtjose) View more | ||||||
Phase 4 | - | - | psfgvasvvr(kqgsnzadiv) = klvptnitcb qlwrbljmwc (lmzdyywjae, 25.2 - 51.9) | - | 29 Apr 2021 | ||
psfgvasvvr(kqgsnzadiv) = zecjhyhsjw qlwrbljmwc (lmzdyywjae, 47.8 - 67.9) | |||||||
Phase 4 | 757 | (Adjuvanted Influenza Vaccine (FLUAD®)) | zilowjdiwf(upnfajooqc): Difference in proportions = -2.7 (95% CI, -5.8 to 0.4) View more | - | 30 Mar 2021 | ||
(High-dose Influenza Vaccine (Fluzone® HD)) | |||||||
Phase 4 | 90 | (Group 1: Fluzone Quadrivalent Influenza Vaccine: 6 to < 36 Months) | pwvqvfkzgu(wxwiubxeeb) = oxbnkpgpcd ksqupwjank (mvsdhogryt, zavroglvuj - xjcupwbtty) View more | - | 17 Dec 2020 | ||
(Group 2: Fluzone Quadrivalent Influenza Vaccine: 3 to < 9 Years) | pwvqvfkzgu(wxwiubxeeb) = wyjsmsmrwi ksqupwjank (mvsdhogryt, eagsjhyaak - nxwcdjfzhc) View more |